The top scientist at GlaxoSmithKline will leave the pharma giant to help lead a start-up founded by a cadre of billionaires who seek immortality. Billionaires including Amazon founder Jeff Bezos and Russian venture capitalist Yuri Milner are funding the biotechnology firm with the aim of discovering a way to reverse aging. Veteran drug developer Hal Barron, 58, will step down …
